Lionel Messi unveils special No. 10 shirt for final Argentina appearance

Guwahati, Sept. 22 -- Lionel Messi has unveiled the special No. 10 Argentina shirt he is set to wear for his final appearance for the national team, offering fans a first look at the jersey marking th... Read More

Jhansi: Woman gangraped, dies by suicide after 6 youths threaten to circulate images

JHANSI, Sept. 22 -- A 19-year-old woman died after allegedly consuming rat poison following a gang-rape by six youths, including three minors, in Jhansi's Gursarai area, police said on Tuesday. Her fa... Read More

Yami Gautam, Kartik Aaryan win big at National Film Awards; 'Article 370' star calls honour 'biggest validation'

India, Sept. 22 -- Yami Gautam and Kartik Aaryan were among the biggest Bollywood names honoured at the 72nd National Film Awards ceremony in Ekta Nagar, Gujarat, on Tuesday. President Droupadi Murmu... Read More

34 divers to search for 120 missing in sunken Virgo Transport 8

Indonesia, Sept. 22 -- The National Search and Rescue Agency (Basarnas) and the Indonesian Navy deploy 34 professional divers on Tuesday to locate the remaining 120 victims trapped inside the hull of ... Read More

InGovern note looks at broader questions raised by fortis audit order; Fortis now before Supreme Court

New Delhi, Sept. 22 -- Proxy advisory firm InGovern has warned that the reasoning behind the Delhi High Court's forensic-audit order against Fortis Healthcare, if it stands, could expose any listed co... Read More

Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More

Singapore Clinical Trial: A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (NEBULA-1)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More

Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More

Singapore Clinical Trial: A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or without Bevacizumab in Comparison to Active Observation with or without Bevacizumab as Maintenance Treatment in Participants with Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muval... Read More

• ««
• «
• 3907
• 3908
• 3909
• 3910
• 3911
• 3912
• 3913
• 3914
• 3915
• 3916
• »
• »»